Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis YL Latour, R Yoon, SE Thomas, C Grant, C Li, M Sena-Esteves, ... Molecular Genetics and Metabolism Reports 21, 100513, 2019 | 52 | 2019 |
Novel biomarkers of human GM1 gangliosidosis reflect the clinical efficacy of gene therapy in a feline model HL Gray-Edwards, DS Regier, JL Shirley, AN Randle, N Salibi, ... Molecular Therapy 25 (4), 892-903, 2017 | 45 | 2017 |
MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis DS Regier, HJ Kwon, J Johnston, G Golas, S Yang, E Wiggs, Y Latour, ... American journal of medical genetics Part A 170 (3), 634-644, 2016 | 42 | 2016 |
Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue L Lemoine, A Ledreux, EJ Mufson, SE Perez, G Simic, E Doran, I Lott, ... Molecular neurodegeneration 15, 1-10, 2020 | 26 | 2020 |
Small neuron-derived extracellular vesicles from individuals with Down syndrome propagate tau pathology in the wildtype mouse brain A Ledreux, S Thomas, ED Hamlett, C Trautman, A Gilmore, ... Journal of clinical medicine 10 (17), 3931, 2021 | 18 | 2021 |
Abnormal intraepidermal nerve fiber density in disease: A scoping review S Thomas, J Enders, A Kaiser, L Rovenstine, L Heslop, W Hauser, ... Frontiers in Neurology 14, 1161077, 2023 | 16 | 2023 |
Ketolysis is required for the proper development and function of the somatosensory nervous system J Enders, J Jack, S Thomas, P Lynch, S Lasnier, X Cao, MT Swanson, ... Experimental neurology 365, 114428, 2023 | 6 | 2023 |
Ketogenic diet prevents methylglyoxal-evoked nociception by scavenging methylglyoxal JD Enders, S Thomas, MT Swanson, JM Ryals, DE Wright Pain 163 (12), e1207-e1216, 2022 | 5 | 2022 |
Development of isogenic human cerebral organoids with beta-galactosidase deficiency YL Latour, SE Thomas, ML Allende, RL Proia, CJ Tifft Molecular Genetics and Metabolism 2 (117), S70-S71, 2016 | | 2016 |